No black box warning on record for Acitretin

As of the latest FDA labeling reviewed, Acitretin (ACITRETIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Acitretin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS ( See also boxed CONTRAINDICATIONS AND WARNINGS .) Hepatotoxicity: Of the 525 subjects treated in US clinical trials, 2 had clinical jaundice with elevated serum bilirubin and transaminases considered related to treatment with acitretin. Liver function test results in these subjects returned to normal after acitretin was discontinued. Two of the 1,289 subjects treated in European clinical

No black box warning on record for Acitretin

Other warnings & precautions

WARNINGS ( See also boxed CONTRAINDICATIONS AND WARNINGS .) Hepatotoxicity: Of the 525 subjects treated in US clinical trials, 2 had clinical jaundice with elevated serum bilirubin and transaminases considered related to treatment with acitretin. Liver function test results in these subjects returned to normal after acitretin was discontinued. Two of the 1,289 subjects treated in European clinical

Acitretin Black Box Warning

No black box warning on record for Acitretin

Other warnings & precautions

Acitretin Black Box Warning

No black box warning on record for Acitretin

Other warnings & precautions